{"id":{"repo_id":"sherbrooke","oai_identifier":"oai:usherbrooke.scholaris.ca:11143/15336"},"canonical_url":"https://search.dev.ndltd.org/etd/sherbrooke/oai:usherbrooke.scholaris.ca:11143/15336","repository":{"repo_id":"sherbrooke","name":"Université de Sherbrooke","base_url":"https://usherbrooke.scholaris.ca/server/oai/request"},"display":{"title":"Les perturbateurs endocriniens : les défis entourant la réglementation de ces substances chimiques au niveau international, canadien et européen","abstract":"Endocrine disrupters (EDs) are chemicals known to prevent the proper functioning of the endocrine system. Their presence in the environment is linked to the prevalence of chronic diseases such as type 2 diabetes, breast, testicular, prostate and brain cancer, obesity, neurobehavioural disorders, but also gender imbalance, fertility disorders and the general decline of intelligence quotient. Pursuant to their intrinsic properties, EDs cannot be treated like any other chemicals, therefore, they cannot be subject to the same risk assessment as the one established in the legislation applicable to chemicals in a general way. Aware of the public health challenges posed by these substances, the European Union has recently banned EDs through its legislation on chemicals, pesticides and biocides. However, in Canada, EDs are not specifically prohibited within chemical or pesticide legislations. Similarly, no binding standards or guidelines are currently in force within the international community. As such, would a specific framework applicable to EDs be essential for the protection of public health? This essay will attempt to highlight this query.","abstract_html":"Endocrine disrupters (EDs) are chemicals known to prevent the proper functioning of the endocrine system. Their presence in the environment is linked to the prevalence of chronic diseases such as type 2 diabetes, breast, testicular, prostate and brain cancer, obesity, neurobehavioural disorders, but also gender imbalance, fertility disorders and the general decline of intelligence quotient. Pursuant to their intrinsic properties, EDs cannot be treated like any other chemicals, therefore, they cannot be subject to the same risk assessment as the one established in the legislation applicable to chemicals in a general way. Aware of the public health challenges posed by these substances, the European Union has recently banned EDs through its legislation on chemicals, pesticides and biocides. However, in Canada, EDs are not specifically prohibited within chemical or pesticide legislations. Similarly, no binding standards or guidelines are currently in force within the international community. As such, would a specific framework applicable to EDs be essential for the protection of public health? This essay will attempt to highlight this query.","abstract_has_math":false,"creators":["Poirier, Janie"],"institution":"Université de Sherbrooke","degree_name":"LL. M.","degree_level":"Maîtrise","degree_discipline":"Droit et politiques de la santé","degree_department":null,"school":null,"contributors":[],"advisors":["Couture-Ménard, Marie-Ève"],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018","date_published":"2018","updated_at":"2026-07-27T21:07:51Z","subjects":["Perturbateur endocrinien","Loi canadienne sur la protection de l'environnement","Approche stratégique de la gestion internationale des produits chimiques (SAICM","REACH","règlement européen de 2009 sur les produits phytopharmaceutiques"],"languages":["fr"],"rights":[],"rights_urls":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11143/15336","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Couture-Ménard, Marie-Ève"]},{"key":"dc:creator","label":"Author","values":["Poirier, Janie"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2019-04-26T19:15:29Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2019-04-26T19:15:29Z"]},{"key":"dc:date.issued","label":"Date","values":["2018"]},{"key":"dc:publisher","label":"Institution","values":["Université de Sherbrooke"]},{"key":"dc:type","label":"Dc Type","values":["Essai"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Droit et politiques de la santé"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Maîtrise"]},{"key":"thesis:degree_name","label":"Degree Name","values":["LL. M."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Université de Sherbrooke"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Perturbateur endocrinien","Loi canadienne sur la protection de l'environnement","Approche stratégique de la gestion internationale des produits chimiques (SAICM","REACH","règlement européen de 2009 sur les produits phytopharmaceutiques"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["fr"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11143/15336"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Endocrine disrupters (EDs) are chemicals known to prevent the proper functioning of the endocrine system. Their presence in the environment is linked to the prevalence of chronic diseases such as type 2 diabetes, breast, testicular, prostate and brain cancer, obesity, neurobehavioural disorders, but also gender imbalance, fertility disorders and the general decline of intelligence quotient. Pursuant to their intrinsic properties, EDs cannot be treated like any other chemicals, therefore, they cannot be subject to the same risk assessment as the one established in the legislation applicable to chemicals in a general way. Aware of the public health challenges posed by these substances, the European Union has recently banned EDs through its legislation on chemicals, pesticides and biocides. However, in Canada, EDs are not specifically prohibited within chemical or pesticide legislations. Similarly, no binding standards or guidelines are currently in force within the international community. As such, would a specific framework applicable to EDs be essential for the protection of public health? This essay will attempt to highlight this query.","Les perturbateurs endocriniens (PE) sont des produits chimiques connus pour empêcher le bon fonctionnement du système endocrinien. Leur présence dans l’environnement est liée à la prévalence de maladies chroniques telles que le diabète de type 2, le cancer du sein, des testicules, de la prostate et du cerveau, l’obésité, les troubles neurocomportementaux, mais aussi au déséquilibre du ratio des sexes, aux troubles de fertilité ainsi qu’à la baisse générale du quotient intellectuel. Les PE ne sont pas des produits chimiques comme les autres compte tenu de leurs propriétés intrinsèques et ne peuvent ainsi faire l’objet de la même évaluation de risque que celle mise en place dans la législation applicable aux produits chimiques. Consciente des enjeux de santé publique que représentent ces substances, l’Union européenne a récemment interdit les PE par le biais de sa législation sur les produits chimiques et celle sur les pesticides et biocides. Le Canada, pour sa part, n’interdit pas particulièrement les PE dans son cadre législatif applicable aux produits chimiques ou aux pesticides. De même, aucune norme ou ligne directrice n’est aujourd’hui en vigueur au sein de la communauté internationale. Un tel cadre spécifiquement applicable aux PE est-il essentiel à la protection de la santé publique? C’est ce que cet essai tentera de mettre en lumière."]},{"key":"dc:title","label":"Title","values":["Les perturbateurs endocriniens : les défis entourant la réglementation de ces substances chimiques au niveau international, canadien et européen"]}]}],"canonical_facts":{"dc:contributor.advisor":["Couture-Ménard, Marie-Ève"],"dc:creator":["Poirier, Janie"],"dc:date.accessioned":["2019-04-26T19:15:29Z"],"dc:date.available":["2019-04-26T19:15:29Z"],"dc:date.issued":["2018"],"dc:description.abstract":["Endocrine disrupters (EDs) are chemicals known to prevent the proper functioning of the endocrine system. Their presence in the environment is linked to the prevalence of chronic diseases such as type 2 diabetes, breast, testicular, prostate and brain cancer, obesity, neurobehavioural disorders, but also gender imbalance, fertility disorders and the general decline of intelligence quotient. Pursuant to their intrinsic properties, EDs cannot be treated like any other chemicals, therefore, they cannot be subject to the same risk assessment as the one established in the legislation applicable to chemicals in a general way. Aware of the public health challenges posed by these substances, the European Union has recently banned EDs through its legislation on chemicals, pesticides and biocides. However, in Canada, EDs are not specifically prohibited within chemical or pesticide legislations. Similarly, no binding standards or guidelines are currently in force within the international community. As such, would a specific framework applicable to EDs be essential for the protection of public health? This essay will attempt to highlight this query.","Les perturbateurs endocriniens (PE) sont des produits chimiques connus pour empêcher le bon fonctionnement du système endocrinien. Leur présence dans l’environnement est liée à la prévalence de maladies chroniques telles que le diabète de type 2, le cancer du sein, des testicules, de la prostate et du cerveau, l’obésité, les troubles neurocomportementaux, mais aussi au déséquilibre du ratio des sexes, aux troubles de fertilité ainsi qu’à la baisse générale du quotient intellectuel. Les PE ne sont pas des produits chimiques comme les autres compte tenu de leurs propriétés intrinsèques et ne peuvent ainsi faire l’objet de la même évaluation de risque que celle mise en place dans la législation applicable aux produits chimiques. Consciente des enjeux de santé publique que représentent ces substances, l’Union européenne a récemment interdit les PE par le biais de sa législation sur les produits chimiques et celle sur les pesticides et biocides. Le Canada, pour sa part, n’interdit pas particulièrement les PE dans son cadre législatif applicable aux produits chimiques ou aux pesticides. De même, aucune norme ou ligne directrice n’est aujourd’hui en vigueur au sein de la communauté internationale. Un tel cadre spécifiquement applicable aux PE est-il essentiel à la protection de la santé publique? C’est ce que cet essai tentera de mettre en lumière."],"dc:identifier.uri":["http://hdl.handle.net/11143/15336"],"dc:language.iso":["fr"],"dc:publisher":["Université de Sherbrooke"],"dc:rights.uri":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"],"dc:subject":["Perturbateur endocrinien","Loi canadienne sur la protection de l'environnement","Approche stratégique de la gestion internationale des produits chimiques (SAICM","REACH","règlement européen de 2009 sur les produits phytopharmaceutiques"],"dc:title":["Les perturbateurs endocriniens : les défis entourant la réglementation de ces substances chimiques au niveau international, canadien et européen"],"dc:type":["Essai"],"thesis:degree_discipline":["Droit et politiques de la santé"],"thesis:degree_level":["Maîtrise"],"thesis:degree_name":["LL. M."],"thesis:institution_name":["Université de Sherbrooke"]},"updated_at":"2026-07-27T21:07:51Z"}